Deutsche Bank
LGND icon

Deutsche Bank’s Ligand Pharmaceuticals LGND Stock Holding History

Deutsche Bank’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-802
Closed -$57K – 5107
2019
Q2 		$57K Sell
802
-99
-11% -$7.29K ﹤0.01% 4464
2019
Q1 		$70K Sell
901
-1,513
-63% -$115K ﹤0.01% 4445
2018
Q4 		$204K Buy
+2,414
New +$257K ﹤0.01% 3864

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Deutsche Bank's LGND Position: Q1 2026 in Review

Deutsche Bank reduced its Ligand Pharmaceuticals (LGND) stake by 0.57% in Q1 2026, selling an estimated $348K and leaving 306,111 shares worth $61.1M. The position accounts for 0.02% of the portfolio, ranked #591.

Deutsche Bank first reported a position in LGND in Q2 2013 and has held it in 52 quarters since. The position peaked at $115M in Q2 2018. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Deutsche Bank held 306,111 shares of Ligand Pharmaceuticals worth $61.1M as of Q1 2026.
  • Deutsche Bank sold 1,760 Ligand Pharmaceuticals shares in Q1 2026, an estimated $348K.
  • Ligand Pharmaceuticals made up 0.02% of Deutsche Bank's portfolio in Q1 2026, its #591 holding.
  • Deutsche Bank first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Ligand Pharmaceuticals position peaked at $115M in Q2 2018.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.